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24.5
Matrix-induced autologous chondrocyte implantation (MACI®): In 
sheep: objective assessments including confocal arthroscopy
M.H. Zheng1, C.W. Jones2, A. Keogh2, D. Fick2, P. Yates2, T.B. Kirk2;
1Centre For Orthopaedic Research, University of Western Australia, 
Nedlands, Western Australia, Australia, 2Centre For Orthopaedic 
Research, University of Western Australia, Nedlands, Australia
Purpose: This study had the dual aims of establishing a multi-
site ovine model of articular cartilage injury repair, whilst also 
FYBNJOJOHUIFFG¾DBDZPGNJOJNBMMZJOWBTJWFMBTFSTDBOOJOHDPOGPDBM
arthroscopy (LSCA) for the postoperative histological assessment of 
cartilage repair. 
Methods and Materials: Defects (Æ6mm) were created in the 
trochlea and medial femoral condyle of twenty-one sheep randomised 
into untreated controls, matrix-induced autologous chondrocyte 
implantation (MACI[Ò]), or unseeded MACI treatment, then further 
divided into 8, 10, and 12 week time points. Repair outcomes 
were examined using LSCA, routine histology, macroscopic ICRS 
evaluation, magnetic resonance imaging (MRI), and tissue stiffness 
testing. Interobserver variability and score system correlation was 
conducted to validate system reliability in assessing cartilage 
repair. 
Results: Assessment of MACI treatment by LSCA, MRI, histology, 
and macroscopic IRCS grading, illustrated improvement in repair 
compared to controls across all modalities. Additionally, MACI 
repair resembled native articular cartilage in early-stage remodeling 
histologically, but the stiffness of the MACI repair was inferior to the 
native tissue. Interobserver analysis of the blinded LSCA scoring 
validated our scoring protocol, with almost perfect agreement 
illustrated (ICC=0.9201). Furthermore, Pearson correlation analysis 
demonstrated that LSCA scoring correlated (P<0.05) to both MRI 
and ICRS grading. 
Conclusions: The assessment of cartilage repair has been primarily 
limited to macroscopic assessment, variable MRI, or destructive 
biopsy. The development of non-destructive LSCA cartilage 
repair assessment will facilitate reliable, high resolution, long-
term monitoring of treated lesions in both experimental animal 
models and clinical patients, by obviating the need for destructive 
mechanical biopsy. 
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High Resolution MRI of Matrix induced autologous chondrocyte 
implantation (MACI®) after 24 months
S. Marlovits1, G. Vekszler2, V. Zimmermann3, S. Trattnig4;
1Vienna, Austria, 2Department Of Traumtology, Medical University 
of Vienna, Vienna, Austria, 3Department Of Traumatology, Medical 
University of Vienna, Vienna, Austria, 4Radiology, Medical University 
Vienna, Vienna, Austria
Purpose: The objectives of this study was to evaluate the radiological 
outcome of MACI® in consecutive patients treated for symptomatic 
articular cartilage defects of the knee joint after 24 months post 
implantation. 
Methods and Materials: This study was a prospective, monocenter, 
cohort study and 21 patients (85.7% males, 14.3% females; mean 
age 35.18 years) were followed for 24 months. The defects were 
localized on femoral condyles (76.2%) and on the patella (23.8%) 
with a mean defect size of 5.1 cm2 (SD=2.1). All defects were treated 
with autologous chondrocytes seeded on a collagen Type I/III 
membrane (MACI®). The radiological outcome was analyzed using 
high resolution magnetic resonance imaging (MRI) and the MOCART 
score system. 
Results: After 24 months 88% of the femoral grafts were completely 
present and in position. 76.5% of the patients showed no signs of 
subchondral bone edema. Complete integration of the graft with the 
surrounding native cartilage was found in 82% and bone integration 
in 94%. Two cases of graft hypertrophy occurred with femoral 
condyle grafts. All cases of graft hypertrophy resolved by 24 months. 
Adhesions occurred in 2 of the 7 patella grafts and no adhesions were 
seen in relation to the femoral condyle grafts. 76% of the femoral 
condyle grafts showed signal intensity equal to cartilage on the PD-
FSE and T2W-FSE sequences and 71% on the 3D-GRE-fs sequence. 
Conclusions: We conclude that MACI® is a successful and therapeutic 
option for the treatment of cartilage lesions of the knee. The absence 
PG B QFSJPTUFBM ¿BQ TJHOJ¾DBOUMZ SFEVDFT SJTLT EVF UP QFSJPTUFBM
hypertrophy.
24.7
Three-dimensional delayed gadolinium enhanced MRI of cartilage 
(dGEMRIC) for in vivo evaluation of reparative cartilage after 
matrix-associated autologous chondrocyte transplantation at 
3.0T – preliminary results
S. Trattnig1, S. Marlovits2, S. Gebetsroither3, P. Szomolanyi3,
O. Stastny4, A. Watanabe5, M. Deimling6, T.C. Mamisch7;
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.S $FOUFS ° )JHI¾FME .S .FEJDBM 6OJWFSTJUZ PG 7JFOOB 7JFOOB
Austria, 4Medizinische Radiologie, Diagnostik Und Intervention, 
Zentralklinikum St.Pölten, St.Pölten, Austria, 5Department Of Clinical 
Research, University of Bern, Bern, Switzerland, 6Medical Solutions, 
Siemens Medical Solutions, Erlangen, Germany, 7Orthopeadic
Surgery, Inselspital, University of Berne, Berne, Switzerland
Purpose: 5PVTFB%(3&TFRVFODFXJUIUXP¿JQBOHMFTGPSE(&.3*$
to evaluate relative glycosaminoglycan content of repair tissue after 
matrix-associated autologous chondrocyte transplantation(MACT). 
Methods and Materials: In a phantom study T1-mapping based 
POB%(3&TFRVFODFXJUIEJGGFSFOU¿JQBOHMF DPNCJOBUJPOTXBT
compared to standard IR sequence at 3.0T. Fifteen patients were 
examined after MACT in the knee at 3–13months (group I), and 19-
42 months (group II). The relaxation rate (R1), calculated for repair 
tissue and normal hyaline cartilage was measured and mean values 
were compared in different postoperative intervals using analysis of 
variance. 
Results: 5IF ¿JQ BOHMF DPNCJOBUJPO  QSPWJEFE UIF CFTU
agreement with IR sequence for short and long T1 values. The mean 
R1 for repair tissue was 2.49 versus 1.04 at the intact control site 
in group I and 1.90 compared to 0.81 in group II. Differences from 
SFQBJS UJTTVF UP DPOUSPM TJUFT TIPXFE TUBUJTUJDBMMZ TJHOJ¾DBODF GPS
CPUIHSPVQTOPTJHOJ¾DBOUEJGGFSFODFXBTGPVOECFUXFFOHSPVQT
Conclusions: 5IF%EVBM¿JQBOHMFE(&.3*$UFDIOJRVFPQUJNJ[FE
for cartilage imaging is comparable to standard T1 IR technique for 
T1 mapping. Furthermore the preliminary in vivo study demonstrates 
the feasibility of the technique in the evaluation of MACT patients. 
29.3
Utilize of Platelet-derived growth factors for the treatment of 
cartilage degenerative pathology
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C. Montaperto3, M. Marcacci5;
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Purpose: 5IFJO¿VFODFPGUIFHSPXUIGBDUPSTPODBSUJMBHFSFQBJSJTOPU
yet widely studied and its application in clinics is still experimental. 
PRP (Platelet Rich Plasma) is a natural concentrate of autologous 
HSPXUIGBDUPSTBOEBDUVBMMZJTXJEFMZFYQFSJNFOUFEJOEJGGFSFOU¾FMET
of medicine. The method is simple, low cost and minimally invasive. 
The aim of our study is to determine the short-term effect of PRP in 
cartilage degenerative pathology. 
Methods and Materials: 30 symptomatic patients (40 knees) 
were treated with autologous PRP intra-articular injections for 
degenerative cartilage pathology. Mean age of the patients was 51 
years (range:35y to 80y). 3 injections were performed every 3 weeks. 
All patients were clinically evaluated at the end of the treatment and 
at 6 months follow up. IKDC, SF36, EQ-VAS, scores were used for 
clinical evaluation and patient stisfaction and functional status were 
also recorded. 
Results: 4UBUJTUJDBMMZ TJHOJ¾DBOU JNQSPWFNFOU PG BMM TDPSFT XBT
detected after treatment and was maintained at 6 months. Subjective 
*,%$ FWBMVBUJPO TIPXFE B TJHOJ¾DBOU TDPSF FOIBODFNFOU GSPN
 CFGPSF UIF USFBUNFOU UP  BGUFS UIF USFBUNFOU 4JHOJ¾DBOU
correlation of clinical outcome with patients age was found. While 
the group of patients less then 60 years old have shown 85% of 
improvement, the group of patients over 60 showed only 30% of 
improvement of clinical outcome. 
Conclusions: Our study have demonstrated a positive effect of 
treatment of degenerative cartilage pathology with Platelet-derived 
growth factors in middle-age patients (<60y) at short term. Medium-
MPOH UFSN TUVEJFT BSF OFFEFE UP DPO¾SN UIF EVSBCJMJUZ PG UIJT
treatment. 
